86 related articles for article (PubMed ID: 29880269)
1. Proton pump inhibitors for Barrett's oesophagus.
Triadafilopoulos G
Gut; 2000 Feb; 46(2):144-6. PubMed ID: 10644301
[No Abstract] [Full Text] [Related]
2. Comment Regarding "Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus".
Zhang H
Gastroenterology; 2024 May; 166(5):943. PubMed ID: 37741421
[No Abstract] [Full Text] [Related]
3. Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases.
Dhaliwal L; Kamboj AK; Williams JL; Chandar AK; Sachdeva K; Gibbons E; Lansing R; Passe M; Perez JA; Avenir KLR; Martin SA; Leggett CL; Chak A; Falk GW; Wani S; Shaheen NJ; Kisiel JB; Iyer PG
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):523-531.e3. PubMed ID: 37716614
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study.
Li Z; Yang K
Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505
[No Abstract] [Full Text] [Related]
5. A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms.
Nason KS; Murphy T; Schindler J; Schipper PH; Hoppo T; Diggs BS; Sauer DA; Shaheen NJ; Morris CD; Jobe BA;
J Clin Gastroenterol; 2013 Oct; 47(9):762-8. PubMed ID: 23751847
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and associated factors of worry for cancer in patients with a Barrett's esophagus.
van der Ende-van Loon MCM; Oude Nijhuis RAB; Curvers WL; Schoon EJ
Sci Rep; 2024 Feb; 14(1):2878. PubMed ID: 38311635
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma.
Juhasz A; Mittal SK; Lee TH; Deng C; Chak A; Lynch HT
J Clin Gastroenterol; 2011; 45(10):867-71. PubMed ID: 21617543
[TBL] [Abstract][Full Text] [Related]
8. Introduction: esophagus, dysplasia, and early esophageal adenocarcinoma: managing the transition.
Sarosi GA
J Gastrointest Surg; 2010 Jun; 14(6):935-6. PubMed ID: 20162375
[No Abstract] [Full Text] [Related]
9. Pattern of presentation of gastroesophageal reflux disease among patients with dyspepsia in Kano, Nigeria.
Maiyaki AS; Borodo MM; Samaila AA; Yakubu A
Ann Afr Med; 2017; 16(4):159-163. PubMed ID: 29063898
[TBL] [Abstract][Full Text] [Related]
10. Precision prevention of oesophageal adenocarcinoma.
Vaughan TL; Fitzgerald RC
Nat Rev Gastroenterol Hepatol; 2015 Apr; 12(4):243-8. PubMed ID: 25666644
[TBL] [Abstract][Full Text] [Related]
11. Barrett's Esophagus.
Bujanda DE; Hachem C
Mo Med; 2018; 115(3):211-213. PubMed ID: 30228724
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus: What do we need to know?
Mohy-Ud-Din N; Krill TS; Shah AR; Chatila AT; Singh S; Bilal M; Parupudi S
Dis Mon; 2020 Jan; 66(1):100850. PubMed ID: 30808502
[TBL] [Abstract][Full Text] [Related]
13. Natural History of Barrett's Esophagus.
Kuipers EJ; Spaander MC
Dig Dis Sci; 2018 Aug; 63(8):1997-2004. PubMed ID: 29905908
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like Factor 5 Promotes Sonic Hedgehog Signaling and Neoplasia in Barrett's Esophagus and Esophageal Adenocarcinoma.
Ng CK; Ma K; Cheng Y; Miyashita T; Harmon JW; Meltzer SJ
Transl Oncol; 2019 Nov; 12(11):1432-1441. PubMed ID: 31401336
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: A comprehensive review for the internist.
Klavan H; Russell MB; Macklin J; Lee E; Aslanian HR; Muniraj T
Dis Mon; 2018 Nov; 64(11):471-487. PubMed ID: 29880269
[No Abstract] [Full Text] [Related]
16. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
Dunbar KB; Souza RF; Spechler SJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
[TBL] [Abstract][Full Text] [Related]
18. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
19. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
